Though it has not reached statistical significance in our study, we showed that this growth factor increased after suppression of K-RasG13D mutation (Figure 2), and it responded to ERK inhibitor and combinational treatments, indicating the self-renewal ability of colon cancer cells was regulated by the mutation. This evidence concerns the gene MAPK1 and colonic neoplasm.